Because previous studies have identified TSLP, IL-25 and IL-33 as potent activators of innate lymphoid cells in allergic and non-allergic disease states [6, 7, 41], we chose to assess potential activation of lung ILC2 by these epithelium-derived cytokines. This evidence concerns the gene IL25 and allergic disease.